Sheesh, that was a rant and a half... Why continue to hold shares in a company he's an exec of if you're so passionate about it?
"So many of the Hopper defenders are those genius long-term investors who bought into IMU at +/- 1c. What all of them conveniently forget is that their investment was made on the back of HER-Vaxx. CF33 wasn't even a thing. Yet Hopper's genius is apparently identifying and acquiring CF33 and his failure with HER-Vaxx and the B-cell platform goes unmentioned."
What "failure" regarding the B-Cell platform are you referring to? I'm no expert here, but when Leslie Chong mentioned excitedly, about a pending update on "Imprinting", I believe she was referring to this platform...so it's very much still part of the whole picture. Just because there hasn't been much talk about the original platforms, doesn't mean they've failed or fallen off the wagon.
I think you've conveniently forgotten that any investments made or to be made are off the back of the incredible IMU research team, and the amazing science at play here.
IMU Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
(20min delay)